Immunofluorescence staining for E-cadherin/vimentin demonstrated that the mesenchymal characteristics of cancer cells were significantly upregulated after treatment with CM, while a number of their epithelial characteristics were retained (Figure 6E). The gene discussed is CDH1; the disease is cancer.